Divalproex, lithium and suicide among Medicaid patients with bipolar disorder.

  title={Divalproex, lithium and suicide among Medicaid patients with bipolar disorder.},
  author={Jon C Collins and Bentson H. Mcfarland},
  journal={Journal of affective disorders},
  volume={107 1-3},
BACKGROUND Suicide completion and attempted suicide are major concerns for people with bipolar disorder. Studies in the private sector have suggested that lithium treatment may be superior to divalproex therapy with regard to minimizing suicidal behavior among individuals with bipolar disorder. However, few data are available regarding Medicaid patients diagnosed with bipolar disorder. METHODS Subjects were 12,662 Oregon Medicaid patients diagnosed with bipolar disorder and treated with… CONTINUE READING
Highly Cited
This paper has 51 citations. REVIEW CITATIONS


Publications citing this paper.
Showing 1-10 of 25 extracted citations

Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry

European Archives of Psychiatry and Clinical Neuroscience • 2012
View 4 Excerpts
Highly Influenced

Pharmacological prevention of suicide in patients with major mood disorders

Neuroscience & Biobehavioral Reviews • 2013
View 1 Excerpt
Highly Influenced

The effect of pharmacotherapy on suicide rates in bipolar patients.

CNS neuroscience & therapeutics • 2012
View 2 Excerpts
Highly Influenced

52 Citations

Citations per Year
Semantic Scholar estimates that this publication has 52 citations based on the available data.

See our FAQ for additional information.